Thank you for your willingness to fill in this survey on advanced in vitro models. In the following paragraphs, we will explain the goal of this survey and what you may expect. Please take the time to read the following information carefully.
For every finished survey, InnoSer will donate €10 to the Limburgs Kankerfonds, a Belgian charity organization funding cancer research.
Goal of this research
The goal of this research is to collect a user's perspective on the use of advanced in vitro models, specifically organoid models and organ-on-a-chip technology. The research is conducted by Master's students Amber Schonk and Meilin Berkhoff on behalf of InnoSer, an innovative contract research organization, striving to develop and provide better preclinical models for drug development. The results of the research will help shape and prioritize key elements required to successfully improve and implement these models. The results are intended to be published as a white paper on the subject of brain organoid models and brain-on-a-chip technology for preclinical drug screening to benefit the broader (scientific) community.
To take part, you will be asked to fill in an online survey taking 10-15 minutes to complete. It is possible to pause the survey and finish it at a later moment. You will be presented a subset of questions relevant to you, based on your previous answers.
Taking part in this survey is voluntary. You may decide to withdraw from participating while filling in the survey. Your answer's are collected anonymously and will not be linked to your personal information.
Data collection and privacy
Data is collected in compliance with GDPR guidelines. It will remain confidential and will only be used for the purposes stated above. Data will be stored for a maximum of 1 year in LimeSurvey, hosted on a local server from InnoSer, unless you express your decision to withdraw from this survey.
If you have further questions on our data collection policy, please contact the email address below.
Results and/or follow-up
If you wish to receive InnoSer's white paper once available, or if you are willing to participate in a short interview in context of this white paper at a later stage, you can leave your email address at the end of the survey.
Feel free to contact us for any concerns or questions by sending an email to firstname.lastname@example.org.
Thank you very much for your time and contribution,
InnoSer's Research & Development Department